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Abstract
Objective—To establish an in vitro model for the investigation of equine corneal wound healing.
To accomplish this goal, a protocol to isolate and culture equine corneal keratocytes, fibroblasts and
myofibroblasts was developed.
Animal material—Equine corneal buttons were aseptically harvested from healthy research horses
undergoing humane euthanasia for reasons unrelated to this study. Slit-lamp biomicroscopy was
performed prior to euthanasia by a board-certified veterinary ophthalmologist to ensure that all
samples were harvested from horses free of anterior segment disease.
Procedure—Equine corneal stroma was isolated using mechanical techniques and stromal sub-
sections were then cultured. Customized media at different culture conditions was used to promote
growth and differentiation of corneal stromal cells into keratocytes, fibroblasts and myofibroblasts.
Results—Cell culture techniques were successfully used to establish a method for the isolation and
culture of equine corneal keratocytes, fibroblasts and myofibroblasts. Immunohistochemical staining
for alpha-smooth muscle and F-actin was used to definitively differentiate the three cell types.
Conclusion—Equine corneal stromal keratocytes, fibroblasts and myofibroblasts can be
predictably isolated and cultured in vitro using this protocol.
Keywords
cornea; corneal wound healing; equine; fibroblasts; keratocytes; myofibroblasts
INTRODUCTION
Corneal transparency is essential for vision. The cornea’s unique structural anatomy acts as
the eye’s first refractive media, accounting for up to 75% of the total refractive state in terrestrial
animals.1,2 Therefore, any ocular disease that affects the cornea’s transparency affects vision.
Corneal disorders are one of the most significant causes of vision loss in the horse. Corneal
wound healing resulting from inflammation, infection, ocular trauma, autoimmune disease or
neoplasia, affects corneal transparency, and therefore vision. When vision is compromised, a
horse’s performance is impaired, and treatment is frequently costly and time consuming.
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The equine cornea ranges between 0.8 and 1.0 mm in thickness.1 It is comprised of four basic
layers: (i) epithelium consisting of 8–10 cell layers (~60 μm), (ii) stroma (~700 μm), (iii)
Descemet’s membrane (14–21 μm) and (iv) endothelium (7 μm).1 The stroma in the cornea is
composed of collagen bundles (85–90%), extracellular matrix and keratocytes, and constitutes
90% of the cornea’s overall thickness. 2 Gap junctions between normal corneal keratocytes
and fibroblasts enable cellular interactions. Corneal trauma resulting in epithelial breakdown
leads to stromal cell activation, protein synthesis, cytokine release, loss of cell to cell contact,
and culminates in the transformation of local keratocytes and fibroblasts to myofibroblasts.2,
3 Numerous cytokines are involved in this process; however, tissue growth factor beta (TGF-
β) has been demonstrated to play a key role in the transdifferentiation of keratocyte to
fibroblasts and myofibroblasts.4 The contractile property of myofibroblasts is due to the
intracellular F-actin microfilament fibers comprising of alpha-smooth muscle actin (α-SMA),
myosin, α-actinin, and associated surface membrane receptors such as α5β1-integrin receptor,
and fibronectin (FN). Contrary to myofibroblasts, quiescent keratocytes are flat interconnected
stellate cells with contractile proteins localized to the cell cortex.2 The process of wound
contracture and corneal healing relies on the presence of myofibroblasts. With the completion
of corneal wound healing, a reduction in myofibroblast number normally occurs. When
myofibroblasts fail to regress in number, abnormal wound healing and corneal fibrosis result.
3
Development of an in vitro model of equine corneal stromal cells is a critical first step in
furthering our understanding of corneal wound healing in this species. Nonetheless, it is
important to note that corneal wound healing is a complex process and may require a battery
of in vitro models. The goal of this study was to reliably isolate pure cultures of equine corneal
keratocytes, fibroblasts and myofibroblasts from healthy equine corneal buttons. These
cultures can be used to study the effects of topical pharmaceuticals, growth factors, and
bacterial toxins on the specific cells.
MATERIALS AND METHODS
Corneal biopsy collection
Full-thickness 6-mm axial corneal buttons were aseptically harvested from five healthy
research horses undergoing humane euthanasia for reasons unrelated to this study. Slit-lamp
biomicroscopy was performed prior to euthanasia to ensure that all samples were harvested
from horses free of anterior segment disease.
Isolation of equine corneal fibroblasts primary cultures
Corneal buttons were washed with minimum essential medium (MEM; Invitrogen, Carlsbad,
CA, USA) and the epithelium and endothelium was removed by gentle scraping using a #15
Bard Parker (BD, Franklin Lakes, NJ, USA) scalpel blade. Corneal stroma was sub-sectioned
and placed in tissue culture plates containing Dulbecco’s modified Eagle’s medium (DMEM;
Invitrogen) containing 10% fetal bovine serum to obtain equine corneal fibroblasts (ECF). ECF
were then incubated in a humidified 5% CO2 incubator (HERA-cell, Thermo Scientific,
Waltham, MA, USA) at 37 °C. In approximately 3–5 days, fibroblasts began migrating from
the stromal sub-sections. Once the primary culture reached 90% confluence, the stromal sub-
sections were manually removed using rat-toothed forceps and discarded. The confluent cells
were trypsinised and re-plated on 60 mm tissue plates in customized media at different culture
conditions to promote growth and differentiation of corneal stromal fibroblasts into keratocytes
and myofibroblasts.
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Isolation of equine corneal keratocytes, fibroblasts and myofibroblasts
Monocultures of corneal keratocytes, fibroblasts and myofibroblasts were selectively induced
from the primary cultures generated from corneal explants by altering media or cell seeding
conditions. Specifically, a concentration of 50 000 cells per 60 mm plate in serum-free MEM
provided equine corneal keratocyte cultures. Equine fibroblast cultures were selectively
produced by seeding 50 000 cells per 12-well plate in MEM medium supplemented with 10%
fetal bovine serum. Myofibroblast cultures were induced from ECF seeding 10 000 fibroblasts
per 60 mm plate in MEM medium supplemented with 10% fetal bovine serum or serum-free
MEM medium containing 1 ng/mL transforming growth factors beta 1 (TGFβ1). The culture
parameters (temperature, humidity, CO2, etc.) remained the same as those described for
obtaining primary ECF cultures.
Immunohistochemistry for corneal stromal cell markers
Immunohistochemistry was used to confirm the presence of equine corneal keratocytes,
fibroblasts and myofibroblasts. Immunofluorescent staining for F-actin and α-SMA was
performed using mouse monoclonal antibody for α-SMA (Invitrogen) and phalloidin
(Invitrogen). Cultured ECF’s were washed with PBS and incubated at room temperature with
monoclonal antibody for either F-actin or α-SMA at a 1:200 dilution in 1× PBS for 90 min and
with secondary antibody Alexa 488 goat anti-mouse IgG (Invitrogen) at a dilution of 1:500 for
1 h. Cells were mounted with Vectashield containing DAPI (Vector Laboratories, Inc.,
Burlingame, CA, USA) to allow visualization of nuclei. Irrelevant isotype-matched primary
antibody, secondary antibody alone, and tissue sections from naïve eyes were used as negative
controls. Immunostained cultures were examined and photographed with Leica fluorescent
microscope (Leica, Wetzlar, Germany) equipped with a CCD digital camera (SpotCam RT
KE, Diagnostic Instruments Inc., Sterling Heights, MI, USA).
Cellular morphology and viability
The cellular phenotype of cultures was monitored with a phase-contrast microscope (Leica
DMIL) equipped with an imaging system (Leica DFC290). The cultures were photographed
at different time intervals to record cellular morphology. Cellular viability of all cell types was
examined using trypan blue assay. Briefly, trypsinised cells were mixed with equal amounts
of cell biology grade 0.4% trypan blue solution (Invitrogen). Dead cells with ruptured
membranes stained blue and live white cells were counted using Neubauer’s chamber. Data
were expressed as percentage of dead cells vs. total cell count.
Quantification using real-time PCR
Total RNA from the cells was extracted using RNeasy kit (Qiagen Inc., Valencia, CA, USA)
and was reverse transcribed to cDNA following vendor’s instructions (Promega, Madison, WI,
USA). Real-time PCR was performed using iQ5 real-time PCR Detection System (Bio-Rad
Laboratories, Hercules, CA, USA). Fifty micro liters reaction mixture containing 2 μL cDNA
(250 ng), 2 μL forward (200 nM); 2 μL reverse primer (200 nM) and 25 μL 2× iQ SYBR green
super mix (Bio-Rad Laboratories) were run at universal cycle (95 °C for 3 min, 40 cycles of
95 °C for 30 s followed by 60 °C for 60 s) following the vendor’s instructions. For α-SMA,
forward primer sequence TGGGTGACGAAGCACAGAGC and reverse primer sequence
CTTCAGGGGCAACACGAAGC were used. Beta actin forward primer
(CGGCTACAGCTTCACCACCA) and reverse primer (CGGGCAGCTCGTAGCTCTTC)
were used as a house keeping gene. The threshold cycle (Ct) was used to detect the increase
in the signal associated with an exponential growth of PCR product during the log-linear phase.
The relative expression was calculated using the following formula, 2−ΔΔCt. The ΔCt
validation experiments showed similar amplification efficiency for all templates used
(difference between linear slopes for all templates <0.1). Results were expressed as mean ±
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SEM. Statistical analysis was performed using an unpaired student t-test in which P < 0.05
was considered significant.
Image and statistical analysis
Statistical analysis was performed using two-way analysis of variance (ANOVA) followed by
Bonferroni multiple comparisons test for viability and other assays. The real-time PCR data
results were analyzed using one-way ANOVA followed by Tukey’s multiple comparison tests.
A ‘P’-value <0.05 was considered significant. The immunocytochemistry data was analyzed
using image J 1.38 X image analysis software (NIH, Bethesda, MD, USA).
RESULTS
Light microscopic examination
Equine corneal fibroblasts, keratocytes and myofibroblasts were cultured using the
methodology described above. The cells grown under serum-free conditions had a similar
morphological appearance as keratocytes in situ, demonstrating long, broad, stellate
cytoplasmic morphology with multiple interconnected cellular processes (Fig. 1a).5 On the
other hand cells grown in 10% serum supplemented medium demonstrated classic spindle
shaped fibroblast morphology (Fig. 1b). Contrary to these observations, equine stromal cell
cultures grown in serum-free medium containing TGFβ1 (1 ng/mL) were larger in size
exhibiting the typical corneal myofibroblastic phenotype (Fig. 1c).5 Keratocytes had the lowest
proliferation rates typical of that observed in vivo in equine cornea while corneal fibroblasts
had the highest proliferation rates reaching confluence in 3–4 days. Keratocyte
transdifferentiation to myofibroblasts under serum-free condition in the presence of TGFβ1
(1 ng/mL) was gradual from day 3 to 10. At day-10, over 90% (P < 0.01) of cells in the culture
grown in the presence of TGFβ1 (1 ng/mL) demonstrated myofibroblastic phenotype whereas
only 4–8% myofibroblasts were observed in the cultures grown in serum-containing (10%)
medium. Keratocytes and myofibroblasts achieved confluence in 10–12 days under serum-free
conditions.
Immunocytochemical evaluation
Immunocytochemistry examinations of phalloidin (F-actin) and α-SMA staining patterns were
unique to each of the three examined equine corneal cell phenotypes. The keratocytes appeared
as a homogenous cell population composed of long, flat, interconnected, stellate cells with F-
actin staining localized to the cell cortex and occasional or no staining of discernable fibers
(Fig. 2a). Cells in cultures fed with 10% serum-containing medium were spindle shaped and
long showing typical fibroblastic phenotype with an intracellular staining for F-actin in
microfilament bundles (Fig. 2b). Myofibroblasts were larger, wider and broader with a
substantial increase in the contractile apparatus that stained distinctively and strong for F-actin
(Fig. 2c). Figure 3 shows immunohistochemistry for α-SMA for the equine corneal cell
phenotypes. Keratocytes did not show positive α-SMA staining (Fig. 3a), fibroblasts
demonstrated sparse α-SMA staining in few cells (Fig. 3b) and myofibroblasts revealed
extremely high α-SMA staining in all the cells (P < 0.01), (Fig. 3c). The sparse α-SMA staining
observed in fibroblasts could be attributable to myofibroblast contamination. Nonetheless, it
is important to mention that even though few fibroblast cells (4–8%) in culture showed high
α-SMA staining they still retained a predominantly fibroblast-like phenotype. It is conceivable
that as the populations of cells shift from one phenotype to another under specific conditions
they may show sparse populations of their previous phenotypes. Senescence in any phenotype
was not observed during this study.
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Viability evaluation
The cellular viability of all three phenotypes was >98% (P < 0.01) as demonstrated by a lack
of positive trypan blue staining. These results suggest that the medium composition and culture
conditions defined for the equine corneal keratocyte, fibroblast and myofibroblast cultures
were optimal for growing and maintaining these cultures for a long time. The trypan assay data
has not been included.
Quantification of real-time PCR
The relative expression of α-SMA quantified using real-time PCR for the three phenotypes has
been shown in Fig. 4. No α-SMA expression was detected in keratocytes whereas
myofibroblasts showed highest α-SMA levels. The quantity of α-SMA mRNA was found to
be >1.5-folds in myofibroblasts compared to keratocytes or fibroblasts (P < 0.01). These results
were consistent with the findings of α-SMA immunocytochemistry.
DISCUSSION
Corneal disease is one of the most common ocular disorders of horses worldwide.6,7
Historically in veterinary ophthalmology, treatment has focused primarily on globe
preservation and restoration of ocular comfort and lesser on the restoration of normal vision,
particularly in cases of severe keratitis. Treatment strategies aiming specifically at the reduction
of corneal scarring are grossly lacking in the horse. Corneal scarring or ‘haze’ as it is referred
to in physician ophthalmology, has been the topic of numerous studies. In hopes to reduce haze
in patients who undergo photorefractive laser eye surgery (PRK, LASIK etc.), experimentation
in mouse, rabbit and human corneas have been completed. Mitomycin C has been proven to
be effective at reducing haze.8–13 Recently, trichostatin A has proved effective in blocking the
effect of TGFβ1 and thereby reducing corneal haze.14 Gene therapy is a new treatment modality
which is demonstrating promise. The decorin gene, which is a natural inhibitor of TGFβ1-3,
successfully introduced into rabbit corneal fibroblasts with adeno-associated virus (AAV)
vector blocked the fibrotic effects of TGFβ1, thereby reducing corneal fibrosis in vitro.15 It
might be a better approach to find agents that prevent rather than treat corneal scarring.
An in vitro model is therefore highly desired for studying wound healing events in the equine
cornea and testing the efficacy of potential therapeutic agents for the prevention and treatment
of corneal scarring in horses. To the best of authors’ knowledge there have been no previous
reports of an in vitro equine corneal wound healing model. Haber et al., examined the effects
of growth factors (EGF, PDGF-BB and TGF-beta 1) on cultured equine epithelial cells and
keratocytes;16,17 however, our investigation differs in that our goal was to successfully
establish three separate, reproducible cell lines from equine stroma only. This study reports
optimal conditions for growing equine corneal keratocytes, fibroblasts and myofibroblasts that
serve as a model for studying various aspects of equine corneal wound healing. The
proliferation rates, morphology, distribution of F-actin and α-SMA marker proteins were
similar to those results published for keratocytes, fibroblasts and myofibroblasts from other
species (canine and rabbit).16–23 We were able to establish the growth of ECF by culturing
corneal stromal sub-sections at cellular density of 50 000 cells/12-well plate in the presence
of serum. The keratocyte phenotype was induced by culturing the ECF under serum-free
conditions whereas equine corneal myofibroblast cultures were obtained by plating the ECF
at a lower density (10 000 cells/60 mm plate) in the presence of serum or in TGFβ1 under
serum-free conditions. These findings are consistent with those reported previously in rabbits
and humans.2,5
Immunohistochemical staining confirmed cell phenotypes via staining patterns of F-actin (Fig.
2) and α-SMA (Fig. 3). Keratocytes are quiescent cells not requiring a significant contractile
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apparatus. Therefore, the presence of F-actin is less prominent and localized to the cortex of
this cell type. Once activated, keratocytes can quickly develop higher levels of F-actin in an
organized arrangement typical of their transformation into fibroblasts. The result is a
morphological change from stellate to spindle shaped. F-actin staining in fibroblasts
demonstrated an increase in F-actin which was more evenly distributed throughout the
cytoplasm in visible bundles. Differentiation of myofibroblasts results in further cellular
enlargement due to activation of protein synthesis and a greater increase in F-actin containing
α-SMA, alpha-actinin and myosin. F-actin staining of myofibroblasts demonstrated prominent
intra-cellular bundles indicative of a well-developed contractile apparatus. The increase in α-
SMA yielded characteristic myofibroblast staining patterns not observed in either keratocyte
or fibroblast cell culture populations.
This novel research model has similar benefits to other established in vitro models including:
practicality, reproducibility, high proliferation rates, ability to control study environment, and
the possibility of cell line cryopreservation. 21–23 Multiple in vitro and in vivo studies
performed in experimental animals have significantly increased our understanding of cellular
and molecular mechanisms involved in the development of corneal haze following keratitis.
17,22 Keratitis causes an alteration in the natural conformation of extracellular matrix and also
changes the cellular density and phenotype of keratocytes.17 These factors result in decreased
corneal tissue transparency, commonly referred to as corneal haze.22 The generation of corneal
myofibroblast cells has recently been identified as the primary biological event responsible for
the formation of corneal stromal opacification.17,23–27 Myofibroblasts are highly contractile
cells with increased backscattering of light attributable to decreased intracellular crystallin
production.27 Induction of myofibroblasts in corneal stroma plays a significant role in corneal
fibrosis and long-term reduction in a clear visual axis.
In summary, the purpose of isolating and culturing equine corneal stromal fibroblasts,
keratocytes, and myofibroblasts was to establish a reproducible in vitro model of pure cultures
of these three cell types. This model will allow further investigation into the study of equine
corneal wound healing. Investigations using anti-fibrotic agents and gene therapy are currently
underway using this model.
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Figure 1.
Light microscopy phase-contrast images of (a) keratocytes demonstrating broad, stellate
cytoplasmic morphology with multiple interconnected cellular processes, (b) fibroblasts
demonstrated a classic spindle shaped morphology, as did (c) myofibroblasts; however, this
phenotype was larger in overall size due to the developed contractile apparatus. Calibration
bar = 100 μm.
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Figure 2.
Immunocytochemical staining with phalloidin (red) showing expression and localization of F-
actin in equine keratocytes, fibroblasts and myofibroblasts. Nuclei are stained blue by DAPI.
Keratocytes (a) demonstrated no positive F-actin staining. Fibroblasts (b) were spindle shaped
with intracellular F-actin bundles. Myofibroblasts (c) demonstrated strong F-actin staining
showing prominent microfilament apparatus. Bar = 100 μm.
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Figure 3.
Immunocytochemical staining showing expression and localization of α-SMA (green) in
equine keratocytes, fibroblasts and myofibroblasts. Nuclei are stained blue by DAPI. Negative
staining in keratocytes (a), sparsely positive in fibroblasts (b) and abundantly positive in
myofibroblasts (c). Bar = 100 μm.
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Figure 4.
Real-time graph demonstrating the results of quantitative real-time PCR measurements of α-
SMA in equine keratocytes, fibroblasts and myofibroblasts. A statistically significant increase
in α-SMA was noted in myofibroblasts compared to keratocytes and fibroblasts. The asterisk
indicates a P < 0.01.
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